S G Mpagama1, K S Msaji2, O Kaswaga2, L J Zurba3, P M Mbelele4, B W Allwood5, B-S Ngungwa2, R M Kisonga2, M Lesosky6, J Rylance7, K Mortimer8. 1. Kibong´oto Infectious Diseases Hospital, Kilimanjaro, Tanzania, Kilimanjaro Christian Medical University College, Kilimanjaro, Tanzania. 2. Kibong´oto Infectious Diseases Hospital, Kilimanjaro, Tanzania. 3. Education for Health Africa, Mount Edgecombe, Durban, South Africa. 4. Kibong´oto Infectious Diseases Hospital, Kilimanjaro, Tanzania, Nelson Mandela African Institution of Science & Technology, Arusha, Tanzania. 5. Division of Pulmonology, Department of Medicine, Stellenbosch University & Tygerberg Hospital, Tygerberg, South Africa. 6. Division of Epidemiology & Biostatistics, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa. 7. Lung Health Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK. 8. Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Abstract
BACKGROUND: Post-TB lung disease (PTLD) is an important but under-recognised chronic respiratory disease in high TB burden settings such as Tanzania. METHODS: This was a cross-sectional survey of adults within 2 years of completion of TB treatment in Kilimanjaro, Tanzania. Data were collected using questionnaires (symptoms and exposures), spirometry and chest radiographs to assess outcome measures, which were correlated with daily life exposures, including environment and diet. RESULTS: Of the 219 participants enrolled (mean age: 45 years ± 10; 193 88% males), 98 (45%) reported chronic respiratory symptoms; 46 (22%) had received treatment for TB two or more times; and HIV prevalence was 35 (16%). Spirometric abnormalities were observed in 146 (67%). Chest X-ray abnormalities occurred in 177 (86%). A diagnosis of PTLD was made in 200 (91%), and half had clinically relevant PTLD. The prevalence of mMRC ≥Grade 3 chronic bronchitis and dyspnoea was respectively 11% and 26%. Older age, multiple episodes of TB and poverty indicators were linked with clinically relevant PTLD. CONCLUSIONS: We found a substantial burden of PTLD in adults who had recently completed TB treatment in Tanzania. There is a pressing need to identify effective approaches for both the prevention and management of this disease.
BACKGROUND: Post-TB lung disease (PTLD) is an important but under-recognised chronic respiratory disease in high TB burden settings such as Tanzania. METHODS: This was a cross-sectional survey of adults within 2 years of completion of TB treatment in Kilimanjaro, Tanzania. Data were collected using questionnaires (symptoms and exposures), spirometry and chest radiographs to assess outcome measures, which were correlated with daily life exposures, including environment and diet. RESULTS: Of the 219 participants enrolled (mean age: 45 years ± 10; 193 88% males), 98 (45%) reported chronic respiratory symptoms; 46 (22%) had received treatment for TB two or more times; and HIV prevalence was 35 (16%). Spirometric abnormalities were observed in 146 (67%). Chest X-ray abnormalities occurred in 177 (86%). A diagnosis of PTLD was made in 200 (91%), and half had clinically relevant PTLD. The prevalence of mMRC ≥Grade 3 chronic bronchitis and dyspnoea was respectively 11% and 26%. Older age, multiple episodes of TB and poverty indicators were linked with clinically relevant PTLD. CONCLUSIONS: We found a substantial burden of PTLD in adults who had recently completed TB treatment in Tanzania. There is a pressing need to identify effective approaches for both the prevention and management of this disease.
Authors: M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger Journal: Eur Respir J Date: 2005-08 Impact factor: 16.671
Authors: Cindy W Leung; Eric L Ding; Paul J Catalano; Eduardo Villamor; Eric B Rimm; Walter C Willett Journal: Am J Clin Nutr Date: 2012-10-03 Impact factor: 7.045
Authors: Matthew R Gingo; Jiayan He; Catherine Wittman; Carl Fuhrman; Joseph K Leader; Cathy Kessinger; Lorrie Lucht; William A Slivka; Yingze Zhang; Deborah K McMahon; Frank C Sciurba; Alison Morris Journal: Eur Respir J Date: 2013-02-21 Impact factor: 16.671
Authors: Pere Almagro; Pablo Martinez-Camblor; Joan B Soriano; Jose M Marin; Inmaculada Alfageme; Ciro Casanova; Cristobal Esteban; Juan J Soler-Cataluña; Juan P de-Torres; Bartolome R Celli; Marc Miravitlles Journal: PLoS One Date: 2014-02-27 Impact factor: 3.240
Authors: G B Migliori; F M Marx; N Ambrosino; E Zampogna; H S Schaaf; M M van der Zalm; B Allwood; A L Byrne; K Mortimer; R S Wallis; G J Fox; C C Leung; J M Chakaya; B Seaworth; A Rachow; B J Marais; J Furin; O W Akkerman; F Al Yaquobi; A F S Amaral; S Borisov; J A Caminero; A C C Carvalho; D Chesov; L R Codecasa; R C Teixeira; M P Dalcolmo; S Datta; A-T Dinh-Xuan; R Duarte; C A Evans; J-M García-García; G Günther; G Hoddinott; S Huddart; O Ivanova; R Laniado-Laborín; S Manga; K Manika; A Mariandyshev; F C Q Mello; S G Mpagama; M Muñoz-Torrico; P Nahid; C W M Ong; D J Palmero; A Piubello; E Pontali; D R Silva; R Singla; A Spanevello; S Tiberi; Z F Udwadia; M Vitacca; R Centis; L D Ambrosio; G Sotgiu; C Lange; D Visca Journal: Int J Tuberc Lung Dis Date: 2021-10-01 Impact factor: 3.427
Authors: Emanuele Pontali; Denise Rossato Silva; Florian M Marx; Jose Antonio Caminero; Rosella Centis; Lia D'Ambrosio; Jose Maria Garcia-Garcia; Jeremiah Chakaya Muhwa; Simon Tiberi; Giovanni Battista Migliori Journal: Arch Bronconeumol Date: 2022-06-10 Impact factor: 6.333
Authors: Denise Rossato Silva; Alana Ambos Freitas; Amanda Reis Guimarães; Lia D'Ambrosio; Rosella Centis; Marcela Muñoz-Torrico; Dina Visca; Giovanni Battista Migliori Journal: J Bras Pneumol Date: 2022-05-13 Impact factor: 2.800
Authors: P M Mbelele; W Sabiiti; S K Heysell; E Sauli; E A Mpolya; S Mfinanga; S H Gillespie; K K Addo; G Kibiki; D J Sloan; S G Mpagama Journal: Int J Tuberc Lung Dis Date: 2022-03-01 Impact factor: 3.427
Authors: Edwin Nuwagira; Joseph Baruch Baluku; David B Meya; Lisa Liang Philpotts; Mark J Siedner; Francis Bajunirwe; Stella G Mpagama; Peggy S Lai Journal: BMJ Open Date: 2022-08-25 Impact factor: 3.006
Authors: A B Binegdie; S Brenac; G Devereux; H Meme; A El Sony; T H Gebremariam; R Osman; B Miheso; B Mungai; L Zurba; M Lesosky; J Balmes; P J Burney; K Mortimer Journal: Int J Tuberc Lung Dis Date: 2022-09-01 Impact factor: 3.427